Bipolar Radiofrequency Ablation -Role in Prevention of Postoperative Atrial Fibrillation
- Conditions
- Postoperative Atrial Fibrillation
- Interventions
- Procedure: Isolation of pulmonary veins with Bipolar radiofrequency ablation
- Registration Number
- NCT00765089
- Lead Sponsor
- University of Pittsburgh
- Brief Summary
Atrial Fibrillation (AF) is one of the most common postoperative complications after coronary artery bypass grafting (CABG). Postoperative AF produces a substantial impact on hospital resources with an estimated annual expenditure of over $1 billion. This includes the cost of pharmacological treatment and the cost of the increased length of stay. The incidence of AF is about 30-40% in CABG patients and increases with age of the patient. As the average age of the patient that undergoes CABG surgery is increasing, it is critical to find a way to prevent or reduce the incidence of this complication.
We propose a prospective, randomized, controlled study to determine the role of pulmonary vein isolation by bipolar ablation in the prevention or reduction of postoperative AF. The block- randomization plan will be used to maintain balance of the study and control arms throughout the study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
- Patients who require an isolated elective CABG surgery on CPB.
- Both male and female patients of age 18 years to 90 years.
- Pre existing atrial fibrillation or history of previous atrial fibrillation.
- Inability to provide informed consent.
- Pregnant or nursing patients.
- Reoperative sternotomy
- Emergency CABG surgery.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pulmonary Vein isolation Isolation of pulmonary veins with Bipolar radiofrequency ablation Patients in this arm will receive pulmonary vein isolation during surgery
- Primary Outcome Measures
Name Time Method Reduced incidence of Postoperative Atrial fibrillation 12 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Pittsburgh Medical Center
🇺🇸Pittsburgh, Pennsylvania, United States